<html>
<head>
  <title>SARS-CoV-2 Spike protein (S) gene N439K literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="S.html">Spike protein (S)</a> gene <span class="constellation">S:p.N439K</span> literature reference collection</h1>
<div class="effect_section"><h2 id="ACE2_receptor_binding_affinity">ACE2 receptor binding affinity</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Enhances RBD:hACE2 affinity approximately 2-fold.<br/>Observed that the N439K mutation results in viral fitness (culture-based) that is similar or possibly slightly improved relative to the wild-type N439 virus (<a href="https://doi.org/10.1016/j.cell.2021.01.037" class="lit_link">Thomson et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="antibody_epitope_effects">Antibody epitope effects</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Decreases in neutralization efficiency up to ~25-50% in the S2D97 mAb.<br/> (<a href="https://doi.org/10.1101/2020.11.04.355842" class="lit_link">Thomson et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Decreases in neutralization efficiency up to ~25-50% in the S2D97 mAb.<br/> (<a href="https://doi.org/10.1101/2020.11.04.355842" class="lit_link">Thomson et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Decreases in neutralization efficiency up to ~15-125% in the REGN10987 mAb.<br/> (<a href="https://doi.org/10.1101/2020.11.04.355842" class="lit_link">Thomson et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Resistent to neutralizing mAb H00S022 (<a href="https://doi.org/10.1016/j.cell.2020.07.012" class="lit_link">Li et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> 6.8% of 442 tested post-infection sera showed a greater than two-fold reduction in binding to N439K RBD as compared to WT. In some individuals, the >two-fold reduction diminished the RBD ED50 response below 30 a threshold previously determined to be a cutoff for specific binding (<a href="https://doi.org/10.1016/j.cell.2021.01.037" class="lit_link">Thomson et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Ablates binding by class 3 mAbs such as C135 that do not directly interfere with ACE2 binding,  but clonal somatic mutations of memory B cells at 6.2 months (evolving humoral immune response)  show pronounced increase in binding to the variant. <br/> (<a href="https://doi.org/10.1101/2020.11.03.367391" class="lit_link">Gaebler et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Resistent to class 3 antibodies (i.e. Abs that do not directly interfere with ACE2 binding).<br/> (<a href="https://doi.org/10.1101/2021.01.15.426911" class="lit_link">Wang et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="convalescent_plasma_escape">Convalescent plasma escape</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Average ~5-fold reduction in neutralization efficacy in convalescent sera of 16 health workers infected in Spring 2020.<br/> (<a href="https://doi.org/10.1101/2021.04.22.441007" class="lit_link">Alenquer et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Observed ~2x decrease on average in neutralization efficacy in convalescent sera of 16 health workers.<br/> (<a href="https://doi.org/10.1101/2021.04.22.441007" class="lit_link">Alenquer et al. (2021)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Resistant to a pool of 10 convalescent sera (but less than 4x, a typical threshold for definition of escape) (<a href="https://doi.org/10.1016/j.cell.2020.07.012" class="lit_link">Li et al. (2020)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="homoplasy">Homoplasy</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> No biochemical data, but high quality non-synonymous homoplasies from a paper, where functional fitness is presumed.<br/> (<a href="https://doi.org/10.1016/j.meegid.2020.104351" class="lit_link">Van Dorp et al. (2020)</a>)</span></li>
<li class="lit_item"><span class="lit_summary"> Mutation has arisen independently multiple times, twice forming significant lineages (<a href="https://doi.org/10.1016/j.cell.2021.01.037" class="lit_link">Thomson et al. (2021)</a>)</span></li>
</ul></div>
<div class="effect_section"><h2 id="monoclonal_antibody_serial_passage_escape">Monoclonal antibody serial passage escape</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> Class 3 antibody C669 and C670 mildly selected for the emergence of the N439K mutation in vitro.<br/> (<a href="https://doi.org/10.1101/2021.01.15.426911" class="lit_link">Wang et al. (2021)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
